Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjan C Lankester

Showing results (31-40 of 160) with videos related to

Pageof 16
Sort By:
Antiviral Therapy|October 1, 2004
Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipientsRůzena Stránská, Anton M van Loon, Merjo Polman, et al.
Pediatric Rheumatology Online Journal|July 29, 2022
The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase DeficiencyJerold Jeyaratnam, Maura Faraci, Andrew R Gennery, et al.
Therapeutic Drug Monitoring|February 4, 2014
Pharmacokinetics of treosulfan in pediatric patients undergoing hematopoietic stem cell transplantationMarloes H Ten Brink, Oliver Ackaert, Juliëtte Zwaveling, et al.
Frontiers in Genome Editing|October 29, 2021
A Small Key for a Heavy Door: Genetic Therapies for the Treatment of HemoglobinopathiesHidde A Zittersteijn, Cornelis L Harteveld, Stefanie Klaver-Flores, et al.
Molecular Immunology|March 20, 2012
Adenovirus type 35, but not type 5, stimulates NK cell activation via plasmacytoid dendritic cells and TLR9 signalingJens H W Pahl, Dirk H J Verhoeven, Kitty M C Kwappenberg, et al.
Clinical Sarcoma Research|May 17, 2012
Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysisDagmar Berghuis, Marco W Schilham, Hanneke I Vos, et al.
Frontiers in Immunology|May 24, 2021
Modeling Influencing Factors in B-Cell Reconstitution After Hematopoietic Stem Cell Transplantation in ChildrenNicolaas G van der Maas, Erik G J von Asmuth, Dagmar Berghuis, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|December 16, 2023
The value of using patient-reported outcomes for health screening during long-term follow-up after paediatric stem cell transplantation for nonmalignant diseasesJoëll E Bense, Nicole Guilonard, Femke Zwaginga, et al.
Pharmacogenomics|November 7, 2013
Effect of genetic variants GSTA1 and CYP39A1 and age on busulfan clearance in pediatric patients undergoing hematopoietic stem cell transplantationMarloes H ten Brink, Tom van Bavel, Jesse J Swen, et al.
Blood Advances|November 15, 2021
Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimenA Birgitta Versluijs, Coco C H de Koning, Arjan C Lankester, et al.
Pageof 16

Showing results (31-40 of 160) with videos related to

Sort By:
Pageof 16
Antiviral Therapy|October 1, 2004
Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipientsRůzena Stránská, Anton M van Loon, Merjo Polman, et al.
Pediatric Rheumatology Online Journal|July 29, 2022
The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase DeficiencyJerold Jeyaratnam, Maura Faraci, Andrew R Gennery, et al.
Therapeutic Drug Monitoring|February 4, 2014
Pharmacokinetics of treosulfan in pediatric patients undergoing hematopoietic stem cell transplantationMarloes H Ten Brink, Oliver Ackaert, Juliëtte Zwaveling, et al.
Frontiers in Genome Editing|October 29, 2021
A Small Key for a Heavy Door: Genetic Therapies for the Treatment of HemoglobinopathiesHidde A Zittersteijn, Cornelis L Harteveld, Stefanie Klaver-Flores, et al.
Molecular Immunology|March 20, 2012
Adenovirus type 35, but not type 5, stimulates NK cell activation via plasmacytoid dendritic cells and TLR9 signalingJens H W Pahl, Dirk H J Verhoeven, Kitty M C Kwappenberg, et al.
Clinical Sarcoma Research|May 17, 2012
Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysisDagmar Berghuis, Marco W Schilham, Hanneke I Vos, et al.
Frontiers in Immunology|May 24, 2021
Modeling Influencing Factors in B-Cell Reconstitution After Hematopoietic Stem Cell Transplantation in ChildrenNicolaas G van der Maas, Erik G J von Asmuth, Dagmar Berghuis, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|December 16, 2023
The value of using patient-reported outcomes for health screening during long-term follow-up after paediatric stem cell transplantation for nonmalignant diseasesJoëll E Bense, Nicole Guilonard, Femke Zwaginga, et al.
Pharmacogenomics|November 7, 2013
Effect of genetic variants GSTA1 and CYP39A1 and age on busulfan clearance in pediatric patients undergoing hematopoietic stem cell transplantationMarloes H ten Brink, Tom van Bavel, Jesse J Swen, et al.
Blood Advances|November 15, 2021
Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimenA Birgitta Versluijs, Coco C H de Koning, Arjan C Lankester, et al.
Pageof 16